相关实验视频
Updated: May 29, 2025

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.2K
KLF5通过向Keap1-Nrf2通路来促进食道状细胞癌的放射电阻
Yang Wang1, Yue-Ying Yang1, Abulajiang Kamili1
1Second Department of Thoracic Surgery, Tumor Hospital Affiliated to Xinjiang Medical University, Xinjiang, 830011, China.
Discover oncology
|February 7, 2025
概括
克鲁佩尔样因子5 (KLF5) 通过抑制Keap1转录和激活Nrf2通路,促进食道状细胞癌 (ESCC) 的放射电阻. 这一发现为改善ESCC治疗结果提供了潜在的治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 食道状细胞癌 (ESCC) 是一个重大的全球卫生挑战,特别是在发展中国家,由于高发病率和死亡率.
- 了解ESCC治疗耐药性的基础分子机制对于开发有效的治疗策略至关重要.
研究的目的:
- 阐明克鲁佩尔样因子5 (KLF5) 在食道状细胞癌中调节放射敏感性的作用.
- 研究KLF5通过哪些分子途径影响ESCC对放射治疗的反应.
主要方法:
- 重量基因共同表达网络分析 (WGCNA) 确定了与ESCC辐射敏感性相关的关键基因.
- 使用RT-qPCR量化KLF5表达水平.
- 细胞测试 (殖民地形成,Transwell,流动细胞计) 评估 KLF5 操纵后的增殖,迁移,入侵和亡.
- 西部斑点,ChIP-seq和双露西法酶试验研究了KLF5/Keap1/Nrf2信号轴.
- 在体内研究涉及异种移植模型,以评估在辐射下瘤进展.
主要成果:
- 确定KLF5是与ESCC辐射敏感性显著相关的核心基因,并且在耐辐射细胞中被上调.
- 过度表达KLF5增强了细胞活力和降低了辐射敏感性,而KLF5倒置降低了放射电阻.
- KLF5的过度表达激活了Nrf2通路并抑制了Keap1的转录,从而导致KLF5/Keap1介导的KLF5/Keap1调节体内瘤的放射电阻.
结论:
- 在食道状细胞癌中,KLF5显著促进放射电阻.
- 该机制涉及KLF5抑制Keap1转录,从而激活Nrf2信号通路.
- 针对KLF5/Keap1/Nrf2轴是一个潜在的治疗策略,可以提高ESCC的辐射敏感性.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Electron Transport Chain: Complex I and II
10.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

